UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma

Nature (London), 2013-11, Vol.503 (7474), p.126-130

2013

Volltextzugriff (PDF)

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2413-2422

2016

Volltextzugriff (PDF)

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Arthritis & rheumatology (Hoboken, N.J.), 2017-06, Vol.69 (6), p.1306-1312

2017

Volltextzugriff (PDF)

Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis

BMC gastroenterology, 2021-04, Vol.21 (1), p.174-174, Article 174

2021

Volltextzugriff (PDF)

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Circulation. Heart failure, 2013-09, Vol.6 (5), p.953-963

2013

Volltextzugriff (PDF)

My Approach to the Treatment of Scleroderma

Mayo Clinic proceedings, 2013-04, Vol.88 (4), p.377-393

2013

Volltextzugriff (PDF)

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2010-07, Vol.182 (2), p.252-260

2010

Volltextzugriff (PDF)

Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma

Rheumatic diseases clinics of North America, 2015-08, Vol.41 (3), p.419-438

2015

Volltextzugriff (PDF)

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

Arthritis care & research (2010), 2017-11, Vol.69 (11), p.1764-1770

2017

Volltextzugriff (PDF)

Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension

Journal of rheumatology, 2010-01, Vol.37 (1), p.98-104

2010

Volltextzugriff (PDF)

Raynaud’s Phenomenon

The New England journal of medicine, 2016-08, Vol.375 (6), p.556-565

2016

Volltextzugriff (PDF)

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Journal of rheumatology, 2009-03, Vol.36 (3), p.576-582

2009

Volltextzugriff (PDF)

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1104-1107

2011

Volltextzugriff (PDF)

Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series

Seminars in arthritis and rheumatism, 2016-10, Vol.46 (2), p.196-199

2016

Volltextzugriff (PDF)

Review: Evidence That Systemic Sclerosis Is a Vascular Disease

Arthritis & rheumatology (Hoboken, N.J.), 2013-08, Vol.65 (8), p.1953-1962

2013

Volltextzugriff (PDF)

Late-age onset systemic sclerosis

Journal of rheumatology, 2011-07, Vol.38 (7), p.1317-1325

2011

Volltextzugriff (PDF)

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma

Arthritis care & research (2010), 2016-08, Vol.68 (8), p.1150-1157

2016

Volltextzugriff (PDF)

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol

Journal of rheumatology, 2009-10, Vol.36 (10), p.2244-2249

2009

Volltextzugriff (PDF)

Enrichment of Scleroderma Vascular Disease–Associated Autoantigens in Endothelial Lineage Cells

Arthritis & rheumatology (Hoboken, N.J.), 2016-10, Vol.68 (10), p.2540-2549

2016

Volltextzugriff (PDF)

Scleroderma patients with combined pulmonary hypertension and interstitial lung disease

Journal of rheumatology, 2003-11, Vol.30 (11), p.2398

2003

Volltextzugriff (PDF)

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans

Medicine (Baltimore), 2014-07, Vol.93 (5), p.177-185

2014

Volltextzugriff (PDF)

Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer

Annals of the rheumatic diseases, 2018-08, p.annrheumdis-2018-212999

2018

Volltextzugriff (PDF)

Current drug therapy for scleroderma and secondary Raynaudʼs phenomenon: evidence-based review

Current opinion in rheumatology, 2007-11, Vol.19 (6), p.611-618

2007

Volltextzugriff (PDF)

Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma

Journal of rheumatology, 2006-02, Vol.33 (2), p.269

2006

Volltextzugriff (PDF)

Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer

Science (American Association for the Advancement of Science), 2014-01, Vol.343 (6167), p.152-157

2014

Volltextzugriff (PDF)

1 – 25 von 292

Suche als RSS-Feed

Aktive Filter

PublikationsformBuchkapitel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(240)

Publikationsform

Sprache

Englisch
(292)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(207)
Life Sciences & Biomedicine
(202)
Humans
(199)
Female
(145)
Rheumatology
(138)
Male
(136)
Middle Aged
(133)
Adult
(119)
Biological And Medical Sciences
(87)
Medical Sciences
(86)
Scleroderma
(85)
Scleroderma, Systemic - Complications
(69)
Aged
(66)
Systemic Sclerosis
(49)
Scleroderma, Systemic - Physiopathology
(40)
General & Internal Medicine
(37)
Diseases Of The Osteoarticular System
(33)
Scleroderma, Systemic - Drug Therapy
(33)
Medicine, General & Internal
(31)
Scleroderma, Systemic - Immunology
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

My Approach to the Treatment of Scleroderma

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension

Raynaud’s Phenomenon

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series

Review: Evidence That Systemic Sclerosis Is a Vascular Disease

Late-age onset systemic sclerosis

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol

Enrichment of Scleroderma Vascular Disease–Associated Autoantigens in Endothelial Lineage Cells

Scleroderma patients with combined pulmonary hypertension and interstitial lung disease

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans

Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer

Current drug therapy for scleroderma and secondary Raynaudʼs phenomenon: evidence-based review

Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma

Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer

Aktive Filter

Suchergebnisse filtern